Evidence map›Paper›PMID 41256161›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Segmentation-Guided Development of Visual Classification Criteria for Alzheimer's Disease.

Mirjam Peters, David Steinbart, Alexander Hammers, Rolf A Heckemann, Alzheimer’s Disease Neuroimaging Initiative

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mirjam PetersDepartment of Medical Radiation Sciences, University of Gothenburg, 41345 Gothenburg, Sweden.
David SteinbartCharité - Universitätsmedizin Berlin, Dept. Neurology, 13353 Berlin, Germany.ORCID 0000-0002-6952-430X
Alexander HammersKing's College London & Guy's and St Thomas' PET Centre, London SE1 7EH, UK.ORCID 0000-0001-9530-4848
Rolf A HeckemannDepartment of Medical Radiation Sciences, University of Gothenburg, 41345 Gothenburg, Sweden.ORCID 0000-0003-3582-3683
Alzheimer’s Disease Neuroimaging Initiative

Funding

Wellcome Trust
6 · The paper itself

Abstract

Alzheimer's disease (AD) causes progressive structural brain changes that precede clinical symptoms by years. Detecting these changes using structural MRI remains challenging, especially in early stages and when relying on visual interpretation alone. Automated semantic segmentation methods offer anatomical precision and objective measurements, but their outputs are rarely used to support human visual assessment. In this study, we explored whether such segmentation outputs can be used to guide a non-expert investigator in developing and applying interpretable diagnostic criteria. We used images from the Alzheimer's Disease Neuroimaging Initiative (ADNI) and implemented a structured, segmentation-informed workflow in which a novice with no prior training in radiology or neuroanatomy developed classification rules based on visual appearance and volumetric readouts through three guided pilot phases. In a fourth phase, the investigator applied these criteria to an independent subset of ADNI images while blinded to the respective ADNI participants' diagnostic labels. Using an anatomical segmentation model (MAPER) with training data from a pre-release version of the Hammers Adult Brain Atlas Database (120 brain regions), the investigator focused on the piriform cortex (PC). The choice of PC was context-driven, reflecting an ongoing quantitative study of PC volume. A binary classification (AD-like versus CN-like) rule based on PC volume (< or > 430

Identifiers

PMID41256161
PMCPMC12622084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.